Real world utilization of 91 day extended levonorgestrel-containing combined oral contraceptives in Europe: a multinational database study.

Levonorgestrel combined oral contraceptives drug utilization ethinyl estradiol extended contraceptives real world data

Journal

Current medical research and opinion
ISSN: 1473-4877
Titre abrégé: Curr Med Res Opin
Pays: England
ID NLM: 0351014

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 19 1 2021
medline: 16 10 2021
entrez: 18 1 2021
Statut: ppublish

Résumé

As part of the risk management plan in Europe, this study was conducted to characterize drug utilization patterns of Seasonique, a 91 day extended levonorgestrel-containing combined oral contraceptive (COC A retrospective observational study was conducted in France, Italy and Belgium using electronic medical record databases obtained from general practitioners (GPs) in all participating countries and gynecologists in France from 2015 to 2018. The study population included women receiving ≥1 prescription of 91 day COC Totals of 235, 220, 207 and 659 women using 91 day COC Findings indicate that 91 day COC

Identifiants

pubmed: 33459071
doi: 10.1080/03007995.2021.1876008
doi:

Substances chimiques

Contraceptives, Oral, Combined 0
Levonorgestrel 5W7SIA7YZW

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

515-522

Auteurs

Sigal Kaplan (S)

Teva Pharmaceutical Industries Ltd., Netanya, Israel.

Massoud Toussi (M)

IQVIA, La Défense, France.

Alison Evans (A)

Drug Safety Research Unit, Southampton, UK.
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.

Sandeep Dhanda (S)

Drug Safety Research Unit, Southampton, UK.
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.

Debabrata Roy (D)

Drug Safety Research Unit, Southampton, UK.
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.

Amir Lass (A)

Theramex Ltd., London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH